This is important in our study because cfDNA is a potential TLR9 inducer and is used as a biomarker in a variety of human chronic inflammatory diseases, such as Systemic Lupus Erythematous (SLE) and Rheumatoid Arthritis (RA)44. The gene discussed is TLR9; the disease is systemic lupus erythematosus.